Xenon Pharmaceuticals Inc (XENE)
Net Income Growth
-47.07%
TTM · Period ending:
XENE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-47.07%period ending
Latest reported-47.07%period ending
XENE TTM Net Income YoY % (503.33% → -47.07%)
Year-over-year change
High-resolution chart · PNG
XENE net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -47.0718% | |
| -52.3846% | |
| -47.6166% | |
| -43.5573% | |
| -39.7709% | |
| -33.3245% | |
| -28.4753% | |
| -21.9047% | |
| -21.576% | |
| -27.9231% | |
| -45.4803% | |
| -54.1676% | |
| -78.2865% | |
| -78.0814% | |
| -58.9374% | |
| -72.9742% | |
| -55.5215% | |
| -123.046% | |
| -173.5444% | |
| -135.3568% | |
| -111.6068% | |
| 1.6456% | |
| 30.672% | |
| 28.0759% | |
| 36.9911% | |
| 10.3248% | |
| -20.5757% | |
| -14.0366% | |
| -61.8573% | |
| -56.1985% | |
| -12.3534% | |
| -18.7166% | |
| 4.3753% | |
| 1.1339% | |
| -33.5131% | |
| -36.8514% | |
| -67.8988% | |
| -176.4073% | |
| -112.5219% | |
| -269.788% | |
| -331.6254% | |
| -232.8706% | |
| -183.1234% | |
| -139.5583% | |
| -35.9896% | |
| -27.7155% | |
| 46.4013% | |
| 188.8754% | |
| 503.3333% |